These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28393965)

  • 21. [Comparison of CTP, MELD, and MELD-Na scores for predicting short term mortality in patients with liver cirrhosis].
    Kim SY; Yim HJ; Lee J; Lee BJ; Kim DI; Jung SW; Han WS; Lee JS; Koo JS; Seo YS; Yeon JE; Lee HS; Lee SW; Um SH; Byun KS; Choi JH; Ryu HS
    Korean J Gastroenterol; 2007 Aug; 50(2):92-100. PubMed ID: 17928752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Impact of Serum 25-Hydroxyvitamin D3 Levels on the Prognosis of Patients with Liver Cirrhosis According to MELD and Child-Pugh Scores.
    Kim TH; Yun SG; Choi J; Goh HG; Lee HA; Yim SY; Choi SJ; Lee YS; Yoon EL; Jung YK; Seo YS; Kim JH; Yim HJ; Yeon JE; Byun KS; Um SH
    J Korean Med Sci; 2020 May; 35(19):e129. PubMed ID: 32419396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
    Bae WK; Lee JS; Kim NH; Kim KA; Moon YS; Oh MK
    Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Child-Pugh, MELD, and ALBI scores for predicting the in-hospital mortality in cirrhotic patients with acute-on-chronic liver failure.
    Peng Y; Qi X; Tang S; Deng H; Li J; Ning Z; Dai J; Hou F; Zhao J; Wang R; Guo X
    Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):971-80. PubMed ID: 27070325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased Survival for Patients With Cirrhosis and Organ Failure in Liver Intensive Care and Validation of the Chronic Liver Failure-Sequential Organ Failure Scoring System.
    McPhail MJ; Shawcross DL; Abeles RD; Chang A; Patel V; Lee GH; Abdulla M; Sizer E; Willars C; Auzinger G; Bernal W; Wendon JA
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1353-1360.e8. PubMed ID: 25240417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
    Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores.
    Kalabay L; Gráf L; Vörös K; Jakab L; Benko Z; Telegdy L; Fekete B; Prohászka Z; Füst G
    BMC Gastroenterol; 2007 Mar; 7():15. PubMed ID: 17394649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Child-Turcotte-Pugh versus model for end stage liver disease score for predicting survival in hospitalized patients with decompensated cirrhosis.
    Chaurasia RK; Pradhan B; Chaudhary S; Jha SM
    J Nepal Health Res Counc; 2013 Jan; 11(23):9-16. PubMed ID: 23787518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study.
    Kalafateli M; Zisimopoulos K; Vourli G; Rigamonti C; Goulis J; Manesis E; Manolakopoulos S; Tsochatzis E; Georgiou A; Diamantopoulou G; Thomopoulos K; Gogos C; Touloumi G; Akriviadis E; Lambropoulou-Karatza C; Triantos C
    Dig Dis Sci; 2017 May; 62(5):1363-1372. PubMed ID: 28251503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical usefulness of DeltaMELD to predict the survival of patients with liver cirrhosis].
    Eun SH; Kim YS; Jang JY; Cheon YG; Kim YS; Cho YD; Lee JS; Lee MS; Kim JH; Shim CS; Kim BS
    Korean J Hepatol; 2006 Dec; 12(4):530-8. PubMed ID: 17237631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit.
    Cholongitas E; Senzolo M; Patch D; Kwong K; Nikolopoulou V; Leandro G; Shaw S; Burroughs AK
    Aliment Pharmacol Ther; 2006 Apr; 23(7):883-93. PubMed ID: 16573791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-dimensional conformal radiotherapy for locally advanced hepatocellular carcinoma with portal vein tumour thrombosis: evaluating effectiveness of the model for end-stage liver disease (MELD) score compared with the Child-Pugh classification.
    Okazaki E; Yamamoto A; Nishida N; Hamuro M; Ogino R; Hosono M; Shimatani Y; Tsutsumi S; Hamamoto S; Sohgawa E; Jogo A; Miki Y
    Br J Radiol; 2016 Jul; 89(1063):20150945. PubMed ID: 27164029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of patients with decompensated cirrhosis at high risk for death: improving the prediction by hepatic venous pressure gradient?
    Park SH; Park HY; Kang JW; Park JS; Shin KJ; Kim CH; Suk KT; Baik GH; Kim JB; Kim DJ; Lee HY
    Hepatogastroenterology; 2012; 59(120):2548-51. PubMed ID: 23178621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].
    Jiang ZS; Jiang JN
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):412-5. PubMed ID: 17631709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis.
    Stauber RE; Wagner D; Stadlbauer V; Palma S; Gurakuqi G; Kniepeiss D; Iberer F; Smolle KH; Haas J; Trauner M
    Liver Int; 2009 Nov; 29(10):1516-20. PubMed ID: 19732329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis.
    Choi PC; Kim HJ; Choi WH; Park DI; Park JH; Cho YK; Sohn CI; Jeon WK; Kim BI
    Liver Int; 2009 Feb; 29(2):221-6. PubMed ID: 18544124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of short-term prognosis on patients with chronic severe hepatitis B using the model for end-stage liver disease].
    Zhou J; He WF; Tang XE
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):416-8. PubMed ID: 17631710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.